mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |